Dec 27 (Reuters) - BioNTech said on Friday
that it had entered into a settlement agreement with the U.S.
National Institutes of Health over the payment of royalties and
other amounts related to its COVID-19 vaccine.
The German company said it would pay $791.5 million to the
U.S. agency as part of the settlement.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Anil
D'Silva)